Director/PDMR Shareholding

RNS Number : 5018P

GlaxoSmithKline PLC

18 February 2016

 

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 18 February 2016 of the following increases in the notional allocation of GSK American Depositary Shares (ADSs) on 16 February 2016, at a price of $40.46 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:

Director/PDMR	Number of ADSs
Dr M M Slaoui	26

Connected Person	Number of ADSs
Dr K Slaoui (Connected Person of Dr M M Slaoui)	9

V A Whyte

Company Secretary

18 February 2016

 

END

 

 

RDSZVLFFQLFLBBQ